Hangzhou Grand Biologic Pharmaceutical, Inc.

This study tests an investigational drug called HZBio1 in people with gout. The goal is to see if it is safe and how well it lowers uric acid levels. Participants receive multiple injections of HZBio1 over several weeks. The trial includes adults aged 18 to 70 with gout and eleva…